TRPC4AP Activators
TRPC4AP activators comprise a group of chemicals that can influence the activity of the TRPC4AP protein, which is intricately involved in calcium signaling and ion channel regulation. These activators exert their effects through diverse mechanisms, collectively targeting cellular pathways that impact TRPC4AP-mediated processes. Thapsigargin, for instance, can raise intracellular calcium levels by inhibiting the sarcoplasmic/endoplasmic reticulum Ca²⁺ ATPase (SERCA). This leads to an indirect activation of TRPC4AP by elevating cytoplasmic calcium concentrations, which may affect downstream calcium signaling events.
Ionomycin functions as an ionophore, facilitating the transport of calcium ions across cell membranes. By enhancing intracellular calcium concentrations, it can modulate TRPC4AP activity, particularly in calcium-related signaling pathways. Additionally, ryanodine, while not a direct activator of TRPC4AP, inhibits ryanodine receptors responsible for calcium release from intracellular stores. Consequently, this interference indirectly influences calcium release pathways and can have downstream effects on TRPC4AP function. Collectively, TRPC4AP activators provide a toolbox of chemicals that can manipulate cellular calcium signaling pathways and, in turn, modulate TRPC4AP activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Inhibits SERCA, leading to increased cytoplasmic calcium levels, potentially influencing TRPC4AP-mediated calcium signaling. | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $96.00 $264.00 | 2 | |
Acts as an ionophore, facilitating calcium ion transport across membranes and impacting intracellular calcium concentrations, affecting TRPC4AP function. | ||||||
(±)-Bay K 8644 | 71145-03-4 | sc-203324 sc-203324A sc-203324B | 1 mg 5 mg 50 mg | $84.00 $196.00 $817.00 | ||
An L-type calcium channel activator, potentially influencing calcium signaling pathways in which TRPC4AP participates. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
An L-type calcium channel blocker that indirectly affects calcium signaling pathways, modulating TRPC4AP function in calcium-related processes. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
A calcium chelator used to buffer intracellular calcium levels, influencing TRPC4AP-mediated calcium signaling pathways. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates PKC, which can modulate calcium signaling pathways involving TRPC4AP by phosphorylating downstream targets. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Acts as an ionophore, facilitating calcium ion transport across cell membranes and potentially affecting TRPC4AP-mediated calcium signaling. | ||||||
Ryanodine | 15662-33-6 | sc-201523 sc-201523A | 1 mg 5 mg | $223.00 $799.00 | 19 | |
Inhibits ryanodine receptors, which are involved in calcium release from intracellular stores, indirectly influencing calcium release pathways associated with TRPC4AP. | ||||||